niyazz-shutterstock-com
Niyazz / Shutterstock.com
5 January 2016BiotechMichael Kahnert

A state of grace

Germany is a hub of innovation. The level of scientific and technological performance is very high, thanks to an excellent research landscape and the highest number of innovative enterprises in the EU. However, Germany is falling short of its potential when it comes to leveraging technology to create new products. Germany has not become less competitive in the race for innovation, yet other countries are proving to be far more dynamic.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotech
28 October 2026   Both companies have agreed to dismiss claims and counterclaims involving Amgen’s 2 mg aflibercept biosimilar, while their wider feud continues.
Biotech
23 October 2026   Following the Federal Circuit’s decision to uphold the invalidation of three patents, the parties are set to drop their remaining claims, despite 10x’s separate multi-million dollar jury win.
Biotech
16 October 2026   All 30 claims of a key DNA sequencing patent have been upheld for a second time, marking another setback in a long-running dispute that has already left Guardant facing a $245 million bill.